The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible for creating antibodies that help the body fight infections. Once the myeloma ...

Once built to fight cancer, CAR‑T therapy is now offering new hope for patients with severe autoimmune disease.

The Jersey Shore alum shared that after years of receiving abnormal pap smear results—which led to closer monitoring by her physicians—further testing through a colposcopy and biopsy revealed her ...